| Symbol | AGXRW |
|---|---|
| Name | AGILE THERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 08540 United States NJ 500 College Road East Suite 300 |
| Telephone | +1 (609) 683-1880 |
| Fax | — |
| — | |
| Website | https://agiletherapeutics.com/ |
| Incorporation | US |
| Incorporated On | 1997 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Ernst & Young LLP; |
| Audit Status | AUDITED |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001261249 |
| Description | Agile Therapeutics, Inc., a womens healthcare company, researches, develops, and Additional info from OTC: |
Pink Current symbol attribute type Security_Name was changed. Previous value: -. New value: AGILE THERAPEUTICS WTS.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: AGILE THERAPEUTICS WTS.
Read moreESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
Read more